GL1X · GenesisL1 explorer

Research workbench

Urate oxidase co-crystallized with uric acid and azide

Analyse Urate oxidase co-crystallized with uric acid and azide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4POE
Type
protein
Length
295 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uricase
EC
1.7.3.3
UniProt
Q00511
Ligands
ACE, NA, AZI
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUricase (EC 1.7.3.3)protein29528% helix, 39% strandQ00511

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • AZI · Azide ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12210.560.7924empty
21810.460.7524AZI

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4POE · Urate oxidase co-crystallized with uric acid and azide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.